Cargando…
Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer
SIMPLE SUMMARY: Breast cancer-related deaths are mainly due to the spread of cancer cells to distant organs (a process termed metastasis). CD82, also known as KAI1, is an established metastasis suppressor that has been documented to be lowly expressed in metastatic breast cancer. Hence, CD82 could p...
Autores principales: | Viera, Maximillian, Yip, George Wai Cheong, Shen, Han-Ming, Baeg, Gyeong Hun, Bay, Boon Huat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431267/ https://www.ncbi.nlm.nih.gov/pubmed/34503296 http://dx.doi.org/10.3390/cancers13174486 |
Ejemplares similares
-
Theranostic Applications of Glycosaminoglycans in Metastatic Renal Cell Carcinoma
por: Hua, San Hue, et al.
Publicado: (2022) -
Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer
por: Al-Khater, Khulood M., et al.
Publicado: (2021) -
Role of Metastasis Suppressor KAI1/CD82 in Different Cancers
por: Yan, Wei, et al.
Publicado: (2021) -
Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma
por: WANG, GENGMING, et al.
Publicado: (2015) -
Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death
por: Khanna, Puja, et al.
Publicado: (2015)